ABECMA

Celgene Corporation

Application Filed: 2018-11-21
Trademark Application Details
Trademark Logo ABECMA

Mark For: ABECMA® trademark registration is intended to cover the categories of pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system. [all]

Status

2021-04-08 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number88202247
Registration Number5958800
Mark Literal ElementsABECMA
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2020-01-14
Basis44(e)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUYes
44D FiledYes
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameCamille M. Miller
Attorney Docket NumberCELG-1846US/
Law Office AssignedN60
Employee NameEL-BAYEH, ALEXANDRA E

Timeline

2018-11-21Application Filed
2019-09-23Location: PUBLICATION AND ISSUE SECTION
2019-10-29Published
2019-10-29Published for Opposition
2019-10-29Status: Live/Pending
2019-10-29Transaction Date
2020-01-14Location: PUBLICATION AND ISSUE SECTION
2020-01-14Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2020-01-14Trademark Registered
2025-01-14Maintenance Early File Date
2026-01-14Maintenance On Time Date
2026-07-14Maintenance Late Fee Date

Trademark Parties (Applicants & Owners)

Party: Celgene Corporation
Address86 Morris Avenue Summit, NEW JERSEY UNITED STATES 07901
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

Camille M. Miller
Cozen O'Connor
1650 Market Street
Suite 2800
Philadelphia, PA, 19103

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
GS0051Pharmaceutical preparations for use in the treatment of multiple myeloma, blood disease, cancer, diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Trademark Filing History

DescriptionDateProceeding Number
REGISTERED-PRINCIPAL REGISTER2020-01-14
PUBLISHED FOR OPPOSITION2019-10-29
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-10-29
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-10-09
APPROVED FOR PUB - PRINCIPAL REGISTER2019-09-19
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2019-09-166328
EXAMINERS AMENDMENT E-MAILED2019-09-166328
EXAMINERS AMENDMENT -WRITTEN2019-09-1693926
EXAMINER'S AMENDMENT ENTERED2019-09-1688888
TEAS/EMAIL CORRESPONDENCE ENTERED2019-09-0569712
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-09-0569712
ASSIGNED TO LIE2019-09-0369712
ASSIGNED TO LIE2019-08-2273296
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED2019-08-14
SUSPENSION LETTER WRITTEN2019-02-2693926
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED2019-02-266332
LETTER OF SUSPENSION E-MAILED2019-02-266332
ASSIGNED TO EXAMINER2019-02-2593926
TEAS VOLUNTARY AMENDMENT RECEIVED2019-02-22
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-12-11
NEW APPLICATION ENTERED IN TRAM2018-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed